Home › Idiopathic Thrombocytopenic Purpura › Texas
Idiopathic Thrombocytopenic Purpura clinical trials in Texas
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Texas.
Cities in Texas
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Texas Oncology - Central South, Austin
- MD Anderson Cancer Center, Houston
- Texas Oncology Gulf Coast, The Woodlands
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Baylor College of Medicine, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Baylor College of Medicine, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Austin Neuromuscular Center, Austin
- Nerve and Muscle Center of Texas, Houston
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.